Barth Syndrome [Barthův syndrom]
- Terms
-
3-metylglutakonová acidurie typu 2
3-metylglutakonová acidurie typu II
MGA typu 2
MGA typu II
-
3-Methylglutaconic Aciduria, Type II
3-Methylglutaconicaciduria Type 2
3-Methylglutaconicaciduria Type II
Cardioskeletal Myopathy with Neutropenia and Abnormal Mitochondria
MGA Type 2
MGA Type II
Rare congenital X-linked disorder of lipid metabolism. Barth syndrome is transmitted in an X-linked recessive pattern. The syndrome is characterized by muscular weakness, growth retardation, DILATED CARDIOMYOPATHY, variable NEUTROPENIA, 3-methylglutaconic aciduria (type II) and decreases in mitochondrial CARDIOLIPIN level. Other biochemical and morphological mitochondrial abnormalities also exist.
- DUI
- D056889 MeSH Browser
- CUI
- M0529363
- History note
- 2010
- Public note
- 2010
Allowable subheadings
- BL
- blood
- CF
- cerebrospinal fluid
- CI
- chemically induced
- CL
- classification
- CO
- complications 1
- DI
- diagnosis 3
- DG
- diagnostic imaging
- DH
- diet therapy
- DT
- drug therapy
- EC
- economics
- EM
- embryology
- EN
- enzymology
- EP
- epidemiology
- EH
- ethnology
- ET
- etiology 1
- GE
- genetics 3
- HI
- history
- IM
- immunology
- ME
- metabolism 2
- MI
- microbiology
- MO
- mortality
- NU
- nursing
- PS
- parasitology
- PA
- pathology 1
- PP
- physiopathology 1
- PC
- prevention & control
- PX
- psychology
- RT
- radiotherapy
- RH
- rehabilitation
- SU
- surgery
- TH
- therapy 1
- UR
- urine
- VE
- veterinary
- VI
- virology
Dilated cardiomyopathy, neutropenia, skeletal myopathy, and abnormal mitochondria Disease MeSH Browser
Noncompaction of Left Ventricular Myocardium, Familial Isolated, X-Linked Disease MeSH Browser